PDCD1 and cancer: One such factor is the interaction of PD-1, CTLA-4, and TIM-3 inhibitory receptors on the T-cell surface with ligands on the surface of the cancer cell, which sends an inhibitory signal to the T-cell to halt its anti-tumor activity, rendering it ineffective against the tumor [92–94].